Search
for
Sort by
Research 211–240 of 1000+
- A Rare Case of Antinuclear Antibody-Negative Systemic Lupus Erythematosus Presenting With Generalized Lymphadenopathy as the Initial Manifestation
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Bioregenerative Applications of the Human Mesenchymal Stem Cell- Derived Secretome: Part-II
- Complications associated with oncological therapy - how to minimize?
- Clinical pearls in dermatology 2018
- Benign Cutaneous Eruptions After Transplantation
- Oral Presentations
- Description of skin lesions
- Low Level Laser and Light Therapy
- Clinical Management in Psychodermatology
- SUMMARIES OF PAPERS
- Cutaneous manifestations of systemic infection in children
- Cutaneous signals of immune system disease
- Case report: Systemic granulomatous disease with vasculitis in a bull due to hairy vetch (Vicia villosa) toxicosis
- Subacute cutaneous lupus erythematosus presenting as erythroderma
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Clinical manifestations of cutaneous lupus erythematosus
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up
- Cutaneous and Ocular Late Complications of Sulfur Mustard in Iranian Veterans
- Methotrexate in dermatology
- The role of nuclear hormone receptors in cutaneous wound repair
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Endocrine-skin interactions
- <i>Acorus calamus</i>: a bio-reserve of medicinal values